Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Acquisition

10 Mar 2014 08:20

RNS Number : 8879B
Reckitt Benckiser Group PLC
10 March 2014
 



 

 

 

Slough, England - March 10, 2014- Reckitt Benckiser Group PLC ("RB") (LSE: RB) today announces that it has signed a definitive agreement to acquire from McNEIL-PPC, Inc, a subsidiary of Johnson & Johnson, the global rights to the K-Y brand ("K-Y"), a leader in intimate lubricants. The transaction is subject to customary regulatory approvals and closing conditions and is expected to close in mid 2014. No employees or fixed assets are included in the purchase.

K-Y started as a prescription medical device in 1917 and switched to over-the-counter in 1980. The brand's clinical and professional heritage is unique in the category and is the underpinning to its trusted and professionally endorsed position. It has been the historical innovator in the category and was the brand that built the female intimacy enhancement segment in lubricants.

K-Y, as a global leader in intimate lubricants with very high trust score amongst women, will sit alongside the RB Powerbrand Durex to create a unique portfolio of brands in the sexual wellbeing category. Its addition will immediately transform RB's sexual well-being category in the USA and Brazil. K-Y will benefit from RB's strong innovation, brand equity investment and go-to-market capabilities.

Net sales of K-Y in 2013 were greater than $100 million. It is sold in over 50 countries around the world, with the US, Canada and Brazil accounting for the majority of 2013 sales.

 

 

For queries contact:

For further information, please contact:

Reckitt Benckiser

Richard Joyce

Director, Investor Relations

Andraea Dawson-Shepherd

SVP, Global Corporate Communication & Affairs

+44 (0)1753 217800

 

 +44 (0)1753 446447

Brunswick (Financial PR)

David Litterick

+44 (0)20 7404 5959

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQURAWRSVAOARR
Date   Source Headline
5th Mar 20194:30 pmRNSDirector Declaration
4th Mar 201911:43 amRNSDirector/PDMR Shareholding
1st Mar 20197:30 amRNSTotal Voting Rights
28th Feb 201911:16 amRNSDirector/PDMR Shareholding
20th Feb 20193:19 pmRNSDirector/PDMR Shareholding
18th Feb 20197:00 amRNSFull Year Results 2018
1st Feb 20198:44 amRNSTotal Voting Rights
16th Jan 20197:05 amRNSRakesh Kapoor to retire as CEO by end of 2019
4th Jan 201911:00 amRNSDirectorate Change
2nd Jan 20192:23 pmRNSDirectorate Change
31st Dec 20181:12 pmRNSTotal Voting Rights
27th Dec 20184:41 pmRNSSecond Price Monitoring Extn
27th Dec 20184:35 pmRNSPrice Monitoring Extension
13th Dec 20189:43 amRNSDirectorate Change
3rd Dec 201810:09 amRNSTotal Voting Rights
19th Nov 201810:11 amRNSDirector Declaration
9th Nov 201811:56 amRNSDirectorate Change
31st Oct 201812:18 pmRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSQ3 2018: Trading Update
1st Oct 20185:17 pmRNSDirector/PDMR Shareholding
1st Oct 201812:34 pmRNSTotal Voting Rights
31st Aug 20184:46 pmRNSTotal Voting Rights
31st Aug 20184:00 pmRNSDirectorate Change
8th Aug 20182:32 pmRNSHolding(s) in Company
1st Aug 20189:43 amRNSTotal Voting Rights
27th Jul 20187:00 amRNSHalf Year Results
2nd Jul 201810:01 amRNSTotal Voting Rights
26th Jun 201810:15 amRNSDirectorate Change
7th Jun 20184:55 pmRNSDirector/PDMR Shareholding
1st Jun 201811:28 amRNSTotal Voting Rights
31st May 20184:35 pmRNSPrice Monitoring Extension
29th May 20183:11 pmRNSDirector/PDMR Shareholding
25th May 20185:34 pmRNSDirector/PDMR Shareholding
9th May 20182:00 pmRNSHolding(s) in Company
8th May 20182:00 pmRNSDirector/PDMR Shareholding
4th May 20184:27 pmRNSDirectorate Change
3rd May 20183:17 pmRNSResult of AGM
1st May 20181:00 pmRNSChange in Director's Details
1st May 20189:30 amRNSTotal Voting Rights
20th Apr 20187:00 amRNSQ1 2018 Trading Update
18th Apr 20182:00 pmRNSHolding(s) in Company
3rd Apr 20189:00 amRNSTotal Voting Rights
28th Mar 20185:23 pmRNSAnnual Financial Report
22nd Mar 20187:00 amRNSOffer Talks Terminated
19th Mar 201811:00 amRNSDirectorate Change
1st Mar 201810:59 amRNSTotal Voting Rights
19th Feb 20187:00 amRNSFinal Results
1st Feb 20189:19 amRNSTotal Voting Rights
2nd Jan 201810:07 amRNSTotal Voting Rights
1st Dec 201710:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.